REGENERON
Live / Allowed — Notice of allowance issued (as of 04 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 17 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98652297
- Mark type
- Stylized text
- Filed
- 17 Jul 2024
- Published for opposition
- 09 Sept 2025
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 010 — Medical apparatus: Medical apparatuses, namely, catheters, combination drug delivery devices sold empty, infusion apparatus for therapeutic purposes, infusion and injection devices for administering drugs, kits for drug delivery comprised of a syringe, needle, catheter, and a cap
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 04 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Sept 2025 — PUBLISHED FOR OPPOSITION
- 03 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 21 Apr 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 21 Apr 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 29 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Jan 2025 — NON-FINAL ACTION E-MAILED